CombiMatrix, a CLIA-certified laboratory, is bringing microarray analysis to the underserved problem of recurrent pregnancy loss as well as to prenatal testing. CombiMatrix performs microarray ...

The test uses microarray analysis to conduct a more comprehensive examination of a fetus's DNA than is possible with the current standard method, karyotyping—a visual analysis of the fetus's ...

Consortium recommends microarray testing as new standard for pediatric genetic diagnosis Date: May 13, 2010 Source: Emory University Summary: An international consortium of genetics experts has ...

Key Issues Microarray analysis identifies more chromosome abnormalities than traditional karyotyping in prenatal testing. Microarrays will also identify findings of unclear clinical significance ...

Microarray analysis is part of a sea change in prenatal testing, according Ronald Wapner, a reproductive genetics expert at NewYork-Presbyterian Hospital/Columbia University Medical Center, who ...

Microarray testing, which uses the same invasive methods as karyotyping — by sampling the chorionic villus cells from the placenta, or amniocentesis, which extracts cells and fetal DNA from ...

The test, called a chromosomal microarray, detected more irregularities that could result in genetic diseases — such as missing or repeated sections of genetic code — than did karyotyping ...

The American Academy of Pediatrics recommends offering chromosomal microarray testing and Fragile X testing to people with autism, to detect or rule out genetic abnormalities that could affect ...

An international consortium of genetics experts has issued a consensus statement recommending chromosomal microarray as the new standard practice for genetic evaluation of children with ...

Abstract Purpose: Chromosomal microarray (CMA) testing provides the highest diagnostic yield for clinical testing of patients with developmental delay (DD), intellectual disability (ID), multiple ...

Women do not necessarily consider the potential significance and ambiguity of the information they could receive from prenatal microarray testing.